Based on Technavio's market sizing methodology, the marine pharmaceuticals market size is predicted to surge by USD 1.56 billion from 2021 to 2026 at a CAGR of 7.73%.
This report entails market segmentations, including:
- Product - Oncology, cardiovascular, anti-infectives, and others
- Geography - North America, Europe, Asia, and Rest of World (ROW)
This market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. The market report offers information on several market vendors, including Amway Corp., BASF SE, BeyondSpring Inc., BioMarin Pharmaceutical Inc., Bristol Myers Squibb Co., Eisai Co. Ltd., GlaxoSmithKline Plc, Guardian Industries Corp., Jazz Pharmaceuticals Plc, Koninklijke DSM NV, Merck KGaA, Nordic Naturals Inc., Pelagia EPAX, Pfizer Inc., Pharma Marine AS, PharmaMar SA, Seagen Inc., and Croda International Plc among others.
What will the Marine Pharmaceuticals Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Market Size for the Forecast Period and Other Important Statistics
Marine Pharmaceuticals Market: Key Drivers, Trends, and Challenges
Based on our research output, there has been a neutral impact on the market growth during and post COVID-19 era. The licensing agreements is notably driving the market growth, although factors such as the regular supply of marine organisms and compounds may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the marine pharmaceuticals industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Market Driver
- The licensing agreements is one of the key drivers supporting the market size growth.
- The licensing agreements in the global market enable the company to expand the reach of the product to multiple nations with relatively less involvement and risk.
- For instance, PharmaMar has a licensing agreement with Boryung Pharm for Zepsyre (lurbinectedin) in South Korea. The licensing agreement will enable the entry of Zepsyre into the South Korean market. I
- Another licensing and marketing agreement took place in the global market between PharmaMar and STA. This agreement involves lurbinectedin, which is an anti-tumor compound under clinical investigation.
- The agreement with Singapore-based STA will allow the entry of lurbinectedin into Australia, New Zealand, and several Asian countries. These licensing agreements will help in increasing the availability of marine pharmaceuticals across the regions, which, in turn, will drive the global market growth during the forecast period.
Key Market Trend
- Marine peptides as anti-infectives is one of the key market trends fueling the market growth.
- The interest of researchers in evaluating the potential of peptides from marine sources as anti-infective agents has increased.
- Marine-derived peptides are specific fragments of protein that act as sources of nitrogen and amino acids and possess various potential physiological functions.
- The primary sources of the peptides include fish, algae, crab, marine bacteria, and fungus.
- Marine peptides can lead to the discovery of new anti-infectives to cater to the demand for new and efficacious antimicrobial compounds. This, in turn, will drive the market size growth during the forecast period.
Key Market Challenge
- The regular supply of marine organisms and compounds is one of the challenges hampering the market size growth.
- For instance, sponges produce a large number of bioactive metabolites. It is interpreted that bioactive metabolites serve as a chemical defence to combat environmental stress factors leading to competition for space and predation.
- The hurdles in the regular supply of raw materials required for a marine pharmaceutical product include the non-availability of efficient technology for the extraction of marine compounds as they are usually found in deep waters and not on the surface of oceans and other water bodies.
- Even when a compound is obtained from a marine source after tackling the challenges, the preservation of the compounds obtained also poses an additional challenge in terms of marine pharmaceutical development.
- Supply feasibility in an economical and eco-friendly manner for marine-derived pharmaceutical products is another challenge that makes it difficult to maintain a regular supply of marine-derived pharmaceutical compounds. Such increasing challenges will hinder the market size growth during the forecast period.
This market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Parent Market Analysis
Technavio categorizes the global marine pharmaceuticals market as a part of the global pharmaceuticals market within the overall healthcare market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the market during the forecast period.
Who are the Major Marine Pharmaceuticals Market Vendors?
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
- Amway Corp.
- BASF SE
- BeyondSpring Inc.
- BioMarin Pharmaceutical Inc.
- Bristol Myers Squibb Co.
- Eisai Co. Ltd.
- GlaxoSmithKline Plc
- Guardian Industries Corp.
- Jazz Pharmaceuticals Plc
- Koninklijke DSM NV
- Merck KGaA
- Nordic Naturals Inc.
- Pelagia EPAX
- Pfizer Inc.
- Pharma Marine AS
- PharmaMar SA
- Seagen Inc.
- Croda International Plc
This statistical study of the market encompasses successful business strategies deployed by the key vendors. The market is concentrated and the vendors are deploying organic and inorganic growth strategies to compete in the market.
Product Insights and News
- BeyondSpring Inc. - The company offers PLINABULIN which is a cell modulator with potential anticancer and chemotherapy-induced neutropenia prevention benefits.
- BioMarin Pharmaceutical Inc. - The company offers the development and commercialization of marine pharmaceutical products for therapies in rare genetic diseases.
- Bristol Myers Squibb Co. - The company offers Marizomib which is a potent proteasome inhibitor being studied as a potential anticancer agent.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Marine Pharmaceuticals Market Value Chain Analysis
Our report provides extensive information on the value chain analysis for the market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
Which are the Key Regions for Marine Pharmaceuticals Market?

For more insights on the market share of various regions Request for a FREE sample now!
38% of the market's growth will originate from North America during the forecast period. The US and Canada are the key markets for marine pharmaceuticals in North America. Market growth in this region will be faster than the growth of the market in Rest of World (ROW).
The high prevalence of elevated TG levels will facilitate the market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
In 2020, the COVID-19 pandemic negatively impacted the regional market. However, in H2 2021, the introduction of COVID-19 vaccines led to a decrease in the number of COVID-19 cases in the region. This has resulted in the resumption of supply chain operations, which has led to the availability of various marine pharmaceutical drugs for the treatment of different forms of carcinoma, pain, and CVD. These factors will drive the growth of the regional market during the forecast period.
What are the Revenue-generating Product Segments in the Marine Pharmaceuticals Market?

To gain further insights on the market contribution of various segments Request for a FREE sample
The market share growth by the oncology segment will be significant during the forecast period. Cancer is among the most frequent causes of death across the globe. Although tremendous progress is underway in cancer therapy R&D, an urgent need for novel oncology drugs still exists. Moreover, the oncology segment will witness robust growth in the global market during the forecast period. Thus, the high incidence of various types of cancer across the globe will be the primary driver for the demand for marine oncology products. Thus, the increasing demand of oncology drugs will drive market growth during the forecast period.
This report provides an accurate prediction of the contribution of all the segments to the growth of the market size and actionable market insights on post COVID-19 impact on each segment.
Marine Pharmaceuticals Market Scope
|
Report Coverage
|
Details
|
Page number
|
120
|
Base year
|
2021
|
Forecast period
|
2022-2026
|
Growth momentum & CAGR
|
Accelerate at a CAGR of 7.73%
|
Market growth 2022-2026
|
$ 1.56 billion
|
Market structure
|
Concentrated
|
YoY growth (%)
|
5.3
|
Regional analysis
|
North America, Europe, Asia, and Rest of World (ROW)
|
Performing market contribution
|
North America at 38%
|
Key consumer countries
|
US, Canada, Germany, UK, and China
|
Competitive landscape
|
Leading companies, Competitive strategies, Consumer engagement scope
|
Key companies profiled
|
Amway Corp., BASF SE, BeyondSpring Inc., BioMarin Pharmaceutical Inc., Bristol Myers Squibb Co., Eisai Co. Ltd., GlaxoSmithKline Plc, Guardian Industries Corp., Jazz Pharmaceuticals Plc, Koninklijke DSM NV, Merck KGaA, Nordic Naturals Inc., Pelagia EPAX, Pfizer Inc., Pharma Marine AS, PharmaMar SA, Seagen Inc., and Croda International Plc
|
Market dynamics
|
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period
|
Customization purview
|
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
|
Request for a FREE sample
What are the Key Data Covered in this Marine Pharmaceuticals Market Report?
- CAGR of the market during the forecast period 2022-2026
- Detailed information on factors that will drive market growth during the next five years
- Precise estimation of the market size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behaviour
- The growth of the marine pharmaceuticals industry across North America, Europe, Asia, and Rest of World (ROW)
- A thorough analysis of the market's competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of market vendors
We can help! Our analysts can customize this report to meet your requirements. Get in touch